Chiara Zecca1, Claudio Gobbi1. Show Affiliations » 1. Multiple Sclerosis Center, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland/Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.
Abstract
Entities: Chemical
Mesh: See more » Antibodies, Monoclonal/therapeutic useAntigens, CD20Antineoplastic AgentsHumansRituximab/therapeutic use
Substances: See more » Antibodies, MonoclonalAntigens, CD20Antineoplastic AgentsRituximab
Year: 2022 PMID: 35411821 DOI: 10.1177/13524585221088734
Source DB: PubMed Journal: Mult Scler ISSN: 1352-4585 Impact factor: 6.312